FBT
VRTX icon

Founders Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Founders Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$19K Hold
160
– – 0.01% 252
2014
Q3 		$18K Hold
160
– – 0.01% 251
2014
Q2 		$15K Hold
160
– – 0.01% 266
2014
Q1 		$11K Hold
160
– – 0.01% 288
2013
Q4 		$12K Hold
160
– – 0.01% 302
2013
Q3 		$12K Hold
160
– – 0.01% 258
2013
Q2 		$13K Buy
+160
New +$11.8K 0.01% 238

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Founders Bank & Trust's VRTX Position: Q4 2014 in Review

Founders Bank & Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2014 at 160 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #252.

Founders Bank & Trust first reported a position in VRTX in Q2 2013 and has held it in 7 quarters since. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • Founders Bank & Trust held 160 shares of Vertex Pharmaceuticals worth $19K as of Q4 2014.
  • Founders Bank & Trust left its Vertex Pharmaceuticals share count unchanged in Q4 2014.
  • Vertex Pharmaceuticals made up 0.01% of Founders Bank & Trust's portfolio in Q4 2014, its #252 holding.
  • Founders Bank & Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.